Tenon Medical, Inc. (TNON) - Dilution Analysis

10-Q filing | 11.6M shares outstanding

10-K filing | 11.3M shares outstanding

S-3 filing: This prospectus relates to the offer and resale of up to an aggregate of 5,428,890 shares of common stock of Tenon Medical, Inc. by the selling stockholders named herein.

8-K filing: Tenon Medical, Inc. issued 2,217,904 shares of common stock and warrants to purchase 2,217,904 shares of common stock at a combined price of $1.285 per share and warrant, resulting in gross proceeds of $2.85 million. ($2.85M proceeds)

10-Q filing | 8.6M shares outstanding

10-Q filing | 8.9M shares outstanding

8-K filing: Tenon Medical, Inc. acquired SImmetry Business from SiVantage, Inc. and SIMPL Business from SIMPL Medical, LLC, issuing shares of common stock as part of the SImmetry acquisition and to Geist and Grawey as part of their employment agreements.

10-Q filing | 7.6M shares outstanding

S-1 filing: This S-1 filing registers the resale of shares of common stock issuable upon the exercise of warrants held by a selling stockholder, with the company not receiving any proceeds from the sale of these shares, but intending to use proceeds from the cash exercise of the warrants for working capital.

8-K filing: Tenon Medical, Inc. completed a registered direct offering and concurrent private placement on March 27, 2025, issuing 615,000 shares of common stock, pre-funded warrants to purchase up to 656,500 shares of common stock, and common warrants to purchase 1,271,500 shares of common stock, for gross proceeds of approximately $2.54 million. ($7.62M proceeds)

8-K filing: Tenon Medical, Inc. completed a registered direct offering and concurrent private placement on March 26, 2025, issuing 615,000 shares of common stock, pre-funded warrants to purchase up to 118,500 shares of common stock, and common warrants to purchase an aggregate of 733,500 shares of common stock, raising gross proceeds of approximately $1.46 million. ($1.46M proceeds)

10-K filing | 5.6M shares outstanding

8-K filing: Tenon Medical, Inc. entered into a warrant exercise inducement offer letter agreement with a holder of existing warrants to purchase common stock, where the holder agreed to exercise the warrants for cash at a reduced price in exchange for new warrants. ($3.0M proceeds)

10-Q filing | 3.1M shares outstanding

S-1/A filing: This prospectus relates to the resale from time to time of up to 2,445,700 shares of common stock of Tenon Medical, Inc.

S-1 filing: This S-1 filing relates to the resale of up to 2,445,700 shares of common stock issuable upon the exercise of Series A and Series B Common Stock purchase warrants by a selling stockholder.

8-K filing: Tenon Medical, Inc. completed a public offering on September 16, 2024, selling 55,000 shares of common stock, pre-funded warrants for 1,167,850 shares, and warrants for 1,222,850 shares at a combined price of $3.68 per share and warrant, resulting in gross proceeds of approximately $4.5 million before deducting fees and expenses. ($13.5M proceeds)

8-K filing: Tenon Medical, Inc. entered into a warrant exercise inducement offer letter agreement with a holder of outstanding Common Stock purchase warrants, where the holder agreed to exercise the Existing Warrants for cash at the exercise price of $3.55 per share in consideration for the Company's agreement to issue new unregistered warrants. ($4.75M proceeds)

S-1/A filing: Tenon Medical, Inc. is offering up to 1,708,428 shares of its common stock, together with common warrants and pre-funded warrants. The company intends to use the proceeds from this offering for sales and marketing activities, clinical studies, and general corporate purposes, including working capital.

S-1 filing: Tenon Medical, Inc. is offering common stock, common warrants, and pre-funded warrants on a best efforts basis. The offering is subject to completion.

10-Q filing | 4.0M shares outstanding

POS AM filing: This POS AM filing relates to the offering of up to 424,807 shares of common stock by the selling stockholder, Lincoln Park Capital Fund, LLC, under a purchase agreement, with proceeds to be used for general corporate purposes, capital expenditures, working capital, and general and administrative expenses.

POS AM filing: This POS AM filing relates to shares of common stock issuable upon the exercise of Tradeable Warrants.

S-1/A filing: This S-1/A filing from Tenon Medical, Inc. details updates on their business, including recent developments such as the retirement of the CFO, a Nasdaq notice regarding listing standards, an exchange offer, and details of Series A and Note offerings.

POS AM filing: The filing relates to the offering of 2,000,000 shares of common stock issuable upon the exercise of Tradeable Warrants, with the proceeds to be used for general corporate purposes.

10-Q filing | 3.7M shares outstanding

POS AM filing: This POS AM filing relates to the offering of 2,000,000 shares of common stock issuable upon the exercise of tradeable warrants.

S-1 filing: This is an S-1 filing for Tenon Medical, Inc. regarding the offering of common stock by the Selling Stockholder Lincoln Park Capital Fund, LLC.

10-K filing | 3.7M shares outstanding

10-Q filing | 2.5M shares outstanding

8-K filing: Stock split 1-for-10 | Outstanding: 22,612,856 → 2,261,285

S-1 filing: This is an S-1 filing for Tenon Medical, Inc. related to the offering of common stock to Lincoln Park Capital Fund, LLC through a purchase agreement, with the company potentially receiving up to $10 million in gross proceeds for general corporate purposes.

10-Q filing | 22.6M shares outstanding

S-1 filing: This S-1 filing by Tenon Medical, Inc. outlines an offering of up to 16,465,422 Units, each consisting of one share of common stock and two warrants, along with pre-funded units and warrants to purchase up to 32,930,844 shares of common stock, to expand commercial launch, marketing and for working capital purposes.

S-3/A filing: Tenon Medical, Inc. is offering common stock through an At-The-Market offering, with Maxim Group LLC acting as the sales agent, for a total proposed amount of up to $5,523,274. The company intends to use the net proceeds to hire additional employees, continue the commercial launch of our product including training clinicians on The CATAMARAN System procedure, continue clinical marketing studies that are focused on capturing post-market safety and efficacy data, gathering system feedback and initiating product refinements, other sales and marketing activities and for working capital and general corporate purposes.

10-Q filing | 11.3M shares outstanding

S-3 filing: Tenon Medical, Inc. is offering common stock through an At-The-Market offering, with Maxim Group LLC acting as the sales agent, for up to $6,700,000.

10-K filing | 11.3M shares outstanding

RW filing: The company is withdrawing the registration statement because it no longer wishes to conduct a public offering of its securities at this time.

S-1 filing: This is an S-1 filing for Tenon Medical, Inc. regarding an offering of 4,444,445 units, each consisting of one share of common stock and one warrant to purchase one share of common stock.

10-Q filing | 11.2M shares outstanding

10-Q filing | 11.2M shares outstanding

10-Q filing | 11.2M shares outstanding

8-K filing: Tenon Medical, Inc. completed an initial public offering of 3,200,000 shares of common stock at $5.00 per share, resulting in gross proceeds of $16,000,000. ($16.0M proceeds)

S-1/A filing: This S-1/A filing outlines a proposed offering of 4,000,000 shares of common stock, with the intention to use the net proceeds to hire additional employees, commence the commercial launch of our product including training clinicians on The CATAMARAN System procedure, initiating clinical marketing studies that are focused on capturing post-market safety data, gathering system feedback and initiating product refinements, other sales and marketing activities and for working capital and general corporate purposes.

S-1/A filing: Tenon Medical, Inc. files an S-1/A registration statement for the registration of 4,120,000 shares of common stock, including 120,000 shares issuable upon the exercise of warrants to The Benchmark Company, LLC as compensation.

S-1/A filing: S-1/A filing for common stock offering.

S-1/A filing: This is an S-1/A filing for Tenon Medical, Inc., a medical device company focused on surgical solutions for sacroiliac joint fixation/fusion, which includes information on common stock being offered, underwriters' warrants, and related risk factors.

S-1/A filing: This S-1/A filing provides information on Tenon Medical, Inc., a medical device company, including details on its business, the terms of its securities, and risk factors associated with investing in its common stock.

S-1 filing: This is an S-1 filing for an initial public offering of common stock. It includes information about the company's business, risks, and recent developments including convertible notes and warrants.